[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1985

Pancreatic CancerAdjuvant Combined Radiation and Chemotherapy Following Curative Resection

Author Affiliations

From the University of Miami (Dr Kalser) and the EMMES Corp (Dr Ellenberg), Potomac, Md.

Arch Surg. 1985;120(8):899-903. doi:10.1001/archsurg.1985.01390320023003
Abstract

• The efficacy of combined radiation and fluorouracil as adjuvant therapy for pancreatic cancer is suggested by a prospective randomized study conducted by the Gastrointestinal Tumor Study Group (GITSG). Twenty-two patients randomized to no adjuvant treatment and 21 to combined therapy were analyzed. Neither life-threatening toxic reaction nor death due to toxic effect was encountered. The study was terminated prematurely because of an unacceptably low rate of accrual combined with the observation of increasingly large survival differences between the study arms. Median survival for the treatment group (20 months) was significantly longer than that observed for the control group (11 months). Four patients, three in the treated and one in the control group, have survived five years or longer following surgery. The extent of the tumor and initial performance status were significantly and independently related to survival.

(Arch Surg 1985;120:899-903)

×